MAPK3 and melanoma: When levels of phosphorylated ERK1/2 were assessed in untreated melanoma cells, it appeared that melanoma cell populations differed in basal levels of active ERK1/2 (Figure 3B), and ERK1/2high populations, DMBC12 and DMBC17 expressed MITF-M at either very low or high levels, respectively.